OR WAIT 15 SECS
LLC. today announced that it has acquired the team and research products of AVOS Life Sciences. The new division of INC Research, now called AVOS Consulting, delivers strategic, operational and financial analysis to help life sciences companies successfully compete in an increasingly challenging global environment. AVOS will operate as an autonomous division within INC Research reporting directly to the chief executive officer, James Ogle,
“We are very pleased to welcome this esteemed group of experts to the INC Research family,” said Ogle.
AVOS offers independent perspectives on the future business environment for healthcare products and services to pharmaceutical, biotech, device and diagnostic companies. Key executives from AVOS, which includes Neil MacAllister, Keith Ruark, Kathleen Griffin, and David Ewbank, have a solid reputation for providing insights into areas such as healthcare trend assessment, business model development, capital allocation, portfolio optimization, accelerated drug development models and pricing and market access.
In addition to providing consulting expertise, members of the AVOS team will dedicate support to INC Research’s innovative Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances. This new approach to sponsor-CRO relationships is designed to drive maximum value for development programs through resource flexibility, corporate efficiency and risk mitigation.